Nifty Pharma Prediction for Tomorrow, Friday 7 August 2026: Index at 21,880 Continues Recovery With Aurobindo Q1 Results Adding Breadth
- August 6, 2026
- Posted by: Kunal Singla
- Category: News
Nifty Pharma Thu: 21,880 (+0.16%). Range: 21,800-21,952. Support 21,720-21,760. Resistance 22,050-22,150. SBI Q1 Fri. Brent $79.28.
The Nifty Pharma prediction for tomorrow for Friday 7 August 2026 is framed by Thursday’s weekly options expiry session where Nifty 50 settled at approximately 24,617 (flat), India VIX touched an intraday low of 10.80 (the calmest reading since Monday), Bank Nifty recovered 240 points to approximately 57,980 and Sensex gained 109 points to approximately 78,690 as IT stocks reversed Wednesday’s decline and Reliance Industries led the session. The Nifty Pharma is the sectoral benchmark for Friday. Brent crude at 79.28 US dollars (up 1.1 percent on Thursday, no formal Iran deal confirmed) and gold at 4,356 US dollars (7-week high on Strait of Hormuz reopening optimism) are the key commodity markers for Friday. The Dow Jones hit a record 54,349 on Wednesday night, providing a positive global backdrop, though South Korea’s Kospi fell 4.08 percent Thursday — the primary overnight risk for Friday. Nifty Pharma gained 0.16 percent Thursday to 21,880 as the Dr Reddy’s shock continued to be absorbed and Aurobindo Pharma Q1 FY27 results (announced Wednesday evening) provided additional sector breadth. Sun Pharma held near its post-Q1 highs. The Nifty Pharma prediction for tomorrow is neutral-to-positive: sector breadth is recovering across multiple companies, not just Sun Pharma, and post-expiry calmer session removes intraday volatility that had been compressing pharma stocks. The Nifty Pharma prediction for tomorrow is shaped above all by SBI Q1 FY27 results, with the board meeting confirmed for Friday August 7: NIM recovery above 3 percent (from Q4 FY26’s 2.93 percent) is the week’s most critical financial metric. Ankit Jaiswal, Senior Research Analyst at Univest, and Kunal Singla, Associate Director at Univest, present the complete Nifty Pharma prediction for tomorrow.
Click Here – Get Free Investment Predictions
Thursday’s Data Behind the Nifty Pharma prediction for tomorrow
| Indicator | Thursday 6 Aug Close | Change |
|---|---|---|
| Nifty Pharma | 21,880 | +0.16% |
| Day Range | 21,800-21,952 | Session high/low |
| Nifty 50 | ~24,617 | Flat (-0.03%) — expiry pinned near max pain 24,600 |
| Sensex | ~78,690 | +109 pts (+0.14%) — IT, Reliance led |
| Bank Nifty | ~57,980 | +240 pts (+0.41%) — private banks partial recovery |
| India VIX | ~12.06 (low 10.80) | Calmest expiry since Monday |
| Brent Crude | $79.28 (+1.1%) | No Iran deal confirmed; slight bounce from $78.44 |
| Gold | $4,356 (+1.2%) | 7-week high on Strait reopening optimism |
| Dow Jones | 54,349 record | +0.49%; strong US backdrop for Friday |
| Kospi | -4.08% | South Korean tech selloff — primary overnight risk |
| SBI Q1 FY27 | Board meeting Friday Aug 7 | NIM recovery above 3% from Q4’s 2.93% is key |
Ankit Jaiswal notes the Nifty Pharma prediction for tomorrow is shaped by three converging factors for Friday: the post-expiry calmer session dynamics (weekly expiry completed today; August monthly series starts fresh Friday), SBI Q1 FY27 results as the binary domestic catalyst, and Brent crude at 79.28 US dollars still below 80 US dollars despite Thursday’s slight 1.1 percent bounce. The Nifty Pharma is the sectoral benchmark for Friday. The Nifty Pharma prediction for tomorrow analysis below maps each factor to its impact on Friday’s likely range and direction.
SBI Q1 FY27 Results: The Nifty Pharma prediction for tomorrow Primary Catalyst for Friday
SBI‘s board meets Friday August 7 to approve Q1 FY27 results. The most critical metric for the Nifty Pharma prediction for tomorrow: domestic NIM, which compressed to 2.93 percent in Q4 FY26 below SBI’s own 3 percent guidance. Ankit Jaiswal maps the Nifty Pharma prediction for tomorrow outcomes: NIM recovery above 3 percent (55 percent probability) triggers SBI up 3-5 percent and Bank Nifty above 58,400 — the primary positive catalyst across all Nifty Pharma prediction for tomorrow setups on Friday. NIM below 2.95 percent (25 percent probability) would reverse Thursday’s partial banking recovery and create the Nifty Pharma prediction for tomorrow bear case for banking-linked assets. Credit growth target is 13-15 percent year-on-year (system-wide 18.3 percent provides sector context), GNPA target below 2.3 percent.
Technical Levels for the Nifty Pharma prediction for tomorrow
| Level Type | Zone |
|---|---|
| Immediate Support | 21,720-21,760 |
| Support 2 | 21,400-21,450 |
| Strong Support / 50 DMA | 21,400-21,450 |
| Immediate Resistance | 22,050-22,150 |
| Key Resistance | 22,380-22,560 |
Kunal Singla observes that the Nifty Pharma prediction for tomorrow enters Friday with India VIX at 12.06 (intraday low 10.80 Thursday), resetting from the weekly series to the August monthly series. The August monthly PCR for Nifty is approximately 1.05-1.10 with max pain near 24,500-24,600 — confirming a well-supported market floor for the Nifty Pharma prediction for tomorrow. The Nifty Pharma prediction for tomorrow’s 22,050-22,150 is the primary resistance that SBI Q1 beat results must clear for the bullish case to be sustained through Friday’s full session.
Global Cues and Iran Deal for the Nifty Pharma prediction for tomorrow
Brent crude at 79.28 US dollars on Thursday (up 1.1 percent from Wednesday’s 78.44 US dollars) signals no formal Iran-US deal was confirmed despite continued Qatar-Oman-Pakistan shuttle diplomacy. The Strait of Hormuz remains partially shut. For the Nifty Pharma prediction for tomorrow, this crude price range of 78-80 US dollars is the structural neutral zone: FMCG and Auto benefit from crude still below 80 US dollars, while ONGC and upstream energy face the same Q2 realization concerns as Thursday. Gold at 4,356 US dollars (7-week high) reflects institutional positioning for Strait reopening — a structural positive for India’s macro balance of payments in this outlook context. The Dow Jones record at 54,349 is the Nifty Pharma prediction for tomorrow’s primary global positive; Kospi’s 4.08 percent fall is the primary global risk. Ankit Jaiswal recommends monitoring Nikkei futures overnight: Nikkei staying above -1.5 percent confirms the Nifty Pharma prediction for tomorrow Asian backdrop is stable.
Key Factors Shaping the Nifty Pharma prediction for tomorrow
- Nifty Pharma gaining for the third consecutive session (Wednesday +1.0%, Thursday +0.16%) confirms the Dr Reddy’s shock absorption is complete. The Nifty Pharma prediction for tomorrow builds on this established positive momentum.
- Aurobindo Pharma Q1 FY27 results (announced Wednesday evening) adding to Sun Pharma’s strong Q1 (+27% PAT) confirms the Nifty Pharma prediction for tomorrow sector breadth is not dependent on one company.
- Post-expiry calmer Friday session removes the expiry-day gamma dynamics that had been creating intraday volatility in pharma stocks. The Nifty Pharma prediction for tomorrow should trend more directionally on Friday.
Stocks to Watch in the Nifty Pharma prediction for tomorrow
Univest analysts flag the following stocks for educational observation in this outlook on Friday. These are not buy or sell recommendations.
Sun Pharma: CMP Rs 1,784. Ankit Jaiswal flags entry Rs 1,766-1,781, target Rs 1,832, SL Rs 1,738. Sun Pharma’s 27 percent Q1 PAT growth anchors the Nifty Pharma prediction for tomorrow with the strongest fundamental support. This is a watch in this outlook.
Cipla: CMP Rs 1,648. Kunal Singla flags entry Rs 1,628-1,645, target Rs 1,698, SL Rs 1,602. Cipla’s diversified India and US portfolio provides sector breadth for the Nifty Pharma prediction for tomorrow. This is a watch in this outlook.
Apollo Hospitals: CMP Rs 8,930. Ankit Jaiswal flags entry Rs 8,840-8,920, target Rs 9,170, SL Rs 8,700. Apollo Hospitals provides domestic healthcare demand insulation from US generic pricing in this outlook. This is a watch in this outlook.
Use the Univest Screener to Track the Nifty Pharma prediction for tomorrow Live on Friday
Trading Strategy for the Nifty Pharma prediction for tomorrow
- 21,720-21,760 is the support for the Nifty Pharma prediction for tomorrow.
- 22,050-22,150 is the first resistance in this outlook. Ankit Jaiswal recommends booking here.
- Track Sun Pharma above Rs 1,790 on Friday as the Nifty Pharma prediction for tomorrow momentum confirmation signal.
- SBI Q1 FY27 positive result improving broad market sentiment would include pharma stocks in this outlook Friday rally.
Risks to the Nifty Pharma prediction for tomorrow
- US FDA warning letters on Indian pharma manufacturing plants creating sector headwinds in this outlook.
- Aurobindo Pharma Q1 disappointing (results announced Wednesday evening) creating secondary sector stress in this outlook.
- Rupee further strengthening from SBI Q1 beat reducing US generic export realizations in this outlook.
Conclusion
The Nifty Pharma prediction for tomorrow for Friday 7 August 2026 is built on Thursday’s close of 21,880 (+0.16%), a calm expiry session with VIX touching 10.80 intraday, and SBI Q1 FY27 results as the binary domestic catalyst. Ankit Jaiswal of Univest identifies 22,050-22,150 as the primary resistance and 21,720-21,760 as the critical support for the Nifty Pharma prediction for tomorrow. NIM recovery above 3 percent is the single most important metric in this outlook for Friday: it confirms SBI’s guidance was achievable and unlocks the banking sector’s bull case across all related Nifty Pharma prediction for tomorrow asset classes.
Kunal Singla of Univest notes that the post-expiry Friday session carries structurally lower intraday volatility than Thursday’s expiry day. The Dow Jones at record 54,349 and IT stocks recovering Thursday both support the Nifty Pharma prediction for tomorrow’s positive bias. Watch the Kospi overnight: stability above -1 percent confirms the Nifty Pharma prediction for tomorrow Asian risk is contained and the SBI result can be traded directionally.
Disclaimer: Data and figures are sourced from publicly available information and may or may not be accurate. Verify with NSE (nseindia.com), BSE (bseindia.com) and MCX (mcxindia.com) before any investment decision. Investments are subject to market risk. Educational purposes only. Not investment advice by Univest (SEBI RA INH000013776).
Download the Univest iOS App or Univest Android App to track live levels and SBI Q1 FY27 result alerts for the Nifty Pharma prediction for tomorrow on Friday.
FAQs on Nifty Pharma Prediction For Tomorrow, 7 August 2026
What is the Nifty Pharma prediction for tomorrow, Friday 7 August 2026?
Ans. The Nifty Pharma prediction for tomorrow is neutral-to-positive. Nifty Pharma gained 0.16 percent Thursday to 21,880, the third consecutive recovery session from Dr Reddy’s shock. Support is 21,720-21,760 and resistance 22,050-22,150 in this outlook.
Which analysts prepared the Nifty Pharma prediction for tomorrow?
Ans. Ankit Jaiswal, Senior Research Analyst, and Kunal Singla, Associate Director at Univest, prepared the Nifty Pharma prediction for tomorrow.
Is the Dr Reddy’s shock fully absorbed in the Nifty Pharma prediction for tomorrow?
Ans. Yes. Three consecutive positive sessions with Aurobindo Pharma Q1 adding breadth confirms the Dr Reddy’s shock is fully absorbed. The Nifty Pharma prediction for tomorrow is now driven by Sun Pharma’s +27% PAT anchor and the broader Q1 results season.
What is Nifty Pharma support and resistance for the prediction for tomorrow?
Ans. Support is 21,720-21,760 and 21,400-21,450. Resistance is 22,050-22,150 and 22,380-22,560 in this outlook.
What stocks are watched in the Nifty Pharma prediction for tomorrow?
Ans. Sun Pharma (Q1 anchor +27%), Cipla (diversified exposure) and Apollo Hospitals (domestic demand) are the three stocks in this outlook.
